Introduction: In persons with type 1 diabetes (T1D) insulin dosing can be adjusted based on trend arrows derived from continuous glucose monitoring (CGM). We propose a slide rule with narrower blood glucose intervals and more classes of insulin sensitivity than are available in current models. Methods: The slide rule was tested in silico, in which a meal was simulated in 100 virtual subjects and the insulin bolus was calculated either in the standard way based on the insulin-to-carbohydrate ratio and the correction factor or according to the slide rule, following which the percentage time spent in range (70–180 mg/dl; %TIR), hypoglycemia ( 180 mg/dl; %THYPER) was compared between the methods during the 4 h after the meal. Slide rule perform...
Background: In type 1 diabetes therapy, precise tuning of postprandial corrective insulin boluses (C...
Aims/hypothesis: Insulin therapy is effective predominantly when dosage is frequently adjusted. Howe...
Type 1 Diabetes (T1D) is an autoimmune disease where the insulin-producing cells are damaged and una...
Introduction: In persons with type 1 diabetes (T1D) insulin dosing can be adjusted based on trend ar...
Background: Providing real-time magnitude and direction of glucose rate-of-change (ROC) via trend ar...
Continuous Glucose Monitoring (CGM) devices have been recently approved by FDA to be used in the typ...
In the daily management of type 1 diabetes (T1D), determining the correct insulin dose to be injecte...
The insulin to carbohydrate ratio (CR) is a parameter used by patients with type 1 diabetes (T1D) to...
Patients with type 1 diabetes (T1D) require lifelong insulin therapy in order to maintain their bloo...
Background: The aim of the study was to determine the effect of an educational intervention on the u...
Type 1 Diabetes is a chronic metabolic disorder that is normally treated by subcutaneous administrat...
The use of personal continuous glucose monitoring (CGM) has expanded dramatically among individuals ...
"A self-tuning algorithm is presented for on-line insulin dosage adjustment in type 1 diabetic patie...
Type 1 diabetes-mellitus implies a life-threatening absolute insulin deficiency. Artificial pancrea...
After assessing previously published methods, we developed a practical approach to adjusting insulin...
Background: In type 1 diabetes therapy, precise tuning of postprandial corrective insulin boluses (C...
Aims/hypothesis: Insulin therapy is effective predominantly when dosage is frequently adjusted. Howe...
Type 1 Diabetes (T1D) is an autoimmune disease where the insulin-producing cells are damaged and una...
Introduction: In persons with type 1 diabetes (T1D) insulin dosing can be adjusted based on trend ar...
Background: Providing real-time magnitude and direction of glucose rate-of-change (ROC) via trend ar...
Continuous Glucose Monitoring (CGM) devices have been recently approved by FDA to be used in the typ...
In the daily management of type 1 diabetes (T1D), determining the correct insulin dose to be injecte...
The insulin to carbohydrate ratio (CR) is a parameter used by patients with type 1 diabetes (T1D) to...
Patients with type 1 diabetes (T1D) require lifelong insulin therapy in order to maintain their bloo...
Background: The aim of the study was to determine the effect of an educational intervention on the u...
Type 1 Diabetes is a chronic metabolic disorder that is normally treated by subcutaneous administrat...
The use of personal continuous glucose monitoring (CGM) has expanded dramatically among individuals ...
"A self-tuning algorithm is presented for on-line insulin dosage adjustment in type 1 diabetic patie...
Type 1 diabetes-mellitus implies a life-threatening absolute insulin deficiency. Artificial pancrea...
After assessing previously published methods, we developed a practical approach to adjusting insulin...
Background: In type 1 diabetes therapy, precise tuning of postprandial corrective insulin boluses (C...
Aims/hypothesis: Insulin therapy is effective predominantly when dosage is frequently adjusted. Howe...
Type 1 Diabetes (T1D) is an autoimmune disease where the insulin-producing cells are damaged and una...